Rina Zakut-Houri
- Oncology top 5%
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 3
- Biotechnology top 5%
- Cancer Research and Treatments 2
-
- RNA modifications and cancer 2
- Biochemical and Molecular Research 2
- Genetics top 10%
- Virus-based gene therapy research 2
-
- Cancer Mechanisms and Therapy 3
-
- Bacteriophages and microbial interactions 1
- Co-authors
- David GivolMoshe OrenBrigitta Bienz-TadmorVered LavieAdam TelermanRobert AmsonHenryk CzosnekDimitrina D. Pravtcheva
- Partner nations
- IsraelUnited States
In The Last Decade
Rina Zakut-Houri
9 papers receiving 764 citations
Peers
Comparison fields: 5 of 60
- Oncology 557
- Biotechnology 165
- Molecular Biology 541
- Genetics 200
- Cancer Research 84
Countries citing papers authored by Rina Zakut-Houri
This map shows the geographic impact of Rina Zakut-Houri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Zakut-Houri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Zakut-Houri more than expected).
Fields of papers citing papers by Rina Zakut-Houri
This network shows the impact of papers produced by Rina Zakut-Houri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Zakut-Houri. The network helps show where Rina Zakut-Houri may publish in the future.
Co-authorship network
The 10 scholars most cited alongside Rina Zakut-Houri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 10 | |
| 2 | 1988 | 31 | |
| 3 | 1987 | 31 | |
| 4 | 1985 | 126 | |
| 5 | 1985 | 206 | |
| 6 | 1984 | 15 | |
| 7 | 1984 | 159 | |
| 8 | 1984 | 42 | |
| 9 | 1983 | 191 |
About Rina Zakut-Houri
Rina Zakut-Houri is a scholar working on Biotechnology, Oncology and Pathology and Forensic Medicine, having authored 9 papers that have together received 811 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers), Virus-based gene therapy research (2 papers), Cancer Research and Treatments (2 papers), Biochemical and Molecular Research (2 papers) and Bacteriophages and microbial interactions (1 paper). The work is most often cited by research in Oncology (557 citations), Biotechnology (165 citations) and Molecular Biology (541 citations). Rina Zakut-Houri has collaborated with scholars based in Israel and United States. Frequent co-authors include David Givol, Moshe Oren, Brigitta Bienz-Tadmor, Vered Lavie, Adam Telerman, Robert Amson, Henryk Czosnek, Dimitrina D. Pravtcheva, F.H. Ruddle and Frank H. Ruddle. Their work appears in journals such as Nature, The EMBO Journal and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.